Aquestive develops oral film drug delivery technology and medicines for patients and pharmaceutical partners. It last closed at $3.70 on Nov 17, down 1.60% on the day. AQST last reported earnings on Tue, Aug 11, 2026. In the past 30 days there were 1 dark pool print totaling $256K, the largest $256K.
Only 1 firm rated AQST in the past 90 days, not enough for a consensus
Average 12-month target
$10.00
▲ 170.3% upside
Based on 1 analyst who set a price target on AQST in the past 90 days. The average target is $10.00, with a high of $10.00 and a low of $10.00, compared with the last close of $3.70.
Highest target$10.00
Average target$10.00
Lowest target$10.00
Latest rating changes
HC Wainwright & Co.Reiterated
Aug 24Buy$10
Date
Firm
Action
Rating
Price target
Aug 24
HC Wainwright & Co.
Reiterated
Buy
$10
Loading…
Technical Analysis
AQST · as of the Nov 17 close · updated after every close
Downtrend
The stock is 4% below its 20 day and 16% below its 50 day average. It is 14% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 42). The nearest support is the swing low (Oct 19) at $3.65, and the nearest resistance the Pivot at $3.72.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 6.4%/day
Key levels
$6.7452 week high+82.2%
$4.32100 day average+16.8%
$4.3150 day average+16.5%
$4.23200 day average+14.3%
$4.18Swing high (Jul 20)+13.0%
$3.8420 day average+3.8%
$3.79Pivot R1+2.4%
$3.72Pivot+0.5%
$3.70Last close
$3.65Swing low (Oct 19)−1.4%
$3.64Pivot S1−1.6%
$2.9352 week low−20.8%
Indicators
RSI (14)
41.83
Middle of its range
Neutral
MACD
-0.18
Above its signal line
Bullish
Stochastic
45.6
Middle of its range
Neutral
ADX (14)
25.0
Trending down
Williams %R
-64.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-46.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.6%
Change over 10 sessions
Bearish
ATR (14)
$0.24
Typical daily range, 6.4% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 14.6%/day
Key levels
$6.7452 week high+82.2%
$4.32100 day average+16.8%
$4.3150 day average+16.5%
$4.23200 day average+14.3%
$4.18Swing high (Jul 20)+13.0%
$3.8420 day average+3.8%
$3.79Pivot R1+2.4%
$3.72Pivot+0.5%
$3.70Last close
$3.65Swing low (Oct 19)−1.4%
$3.64Pivot S1−1.6%
$2.9352 week low−20.8%
Indicators
RSI (14)
42.79
Middle of its range
Neutral
MACD
-0.13
Below its signal line
Bearish
Stochastic
14.7
Near the bottom of its range
Oversold
ADX (14)
19.0
No clear trend
Williams %R
-84.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-81.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−22.6%
Change over 10 sessions
Bearish
ATR (14)
$0.54
Typical daily range, 14.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for AQST
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AQST did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow AQST usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AQST has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AQST is in one of them and how their past AQST trades turned out.
Aquestive Therapeutics is a pharmaceutical company that develops medicines using oral film and other drug delivery technologies. Its PharmFilm product is a thin film that dissolves in the mouth, and it is used to deliver prescription medicines. The company is developing Anaphylm, an epinephrine treatment for severe allergic reactions that dissolves under the tongue. It also manufactures licensed products that partner companies sell to patients and physicians. Aquestive is headquartered in Warren, New Jersey, and produces its products at a facility in Portage, Indiana.